Livia A Veress1, Dana R Anderson2, Tara B Hendry-Hofer2, Paul R Houin2, Jacqueline S Rioux2, Rhonda B Garlick2, Joan E Loader2, Danielle C Paradiso2, Russell W Smith2, Raymond C Rancourt2, Wesley W Holmes2, Carl W White2. 1. *Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045 and Medical Toxicology Branch/Analytical Toxicology Division U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400, Maryland Livia.Veress@ucdenver.edu. 2. *Department of Pediatrics, University of Colorado Denver, Aurora, Colorado 80045 and Medical Toxicology Branch/Analytical Toxicology Division U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400, Maryland.
Abstract
RATIONALE: Sulfur mustard (SM) is a chemical weapon stockpiled today in volatile regions of the world. SM inhalation causes a life-threatening airway injury characterized by airway obstruction from fibrin casts, which can lead to respiratory failure and death. Mortality in those requiring intubation is more than 80%. No therapy exists to prevent mortality after SM exposure. Our previous work using the less toxic analog of SM, 2-chloroethyl ethyl sulfide, identified tissue plasminogen activator (tPA) an effective rescue therapy for airway cast obstruction (Veress, L. A., Hendry-Hofer, T. B., Loader, J. E., Rioux, J. S., Garlick, R. B., and White, C. W. (2013). Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am. J. Respir. Cell Mol. Biol. 48, 439-447). It is not known if exposure to neat SM vapor, the primary agent used in chemical warfare, will also cause death due to airway casts, and if tPA could be used to improve outcome. METHODS: Adult rats were exposed to SM, and when oxygen saturation reached less than 85% (median: 6.5 h), intratracheal tPA or placebo was given under isoflurane anesthesia every 4 h for 48 h. Oxygen saturation, clinical distress, and arterial blood gases were assessed. Microdissection was done to assess airway obstruction by casts. RESULTS: Intratracheal tPA treatment eliminated mortality (0% at 48 h) and greatly improved morbidity after lethal SM inhalation (100% death in controls). tPA normalized SM-associated hypoxemia, hypercarbia, and lactic acidosis, and improved respiratory distress. Moreover, tPA treatment resulted in greatly diminished airway casts, preventing respiratory failure from airway obstruction. CONCLUSIONS: tPA given via airway more than 6 h after exposure prevented death from lethal SM inhalation, and normalized oxygenation and ventilation defects, thereby rescuing from respiratory distress and failure. Intra-airway tPA should be considered as a life-saving rescue therapy after a significant SM inhalation exposure incident.
RATIONALE: Sulfur mustard (SM) is a chemical weapon stockpiled today in volatile regions of the world. SM inhalation causes a life-threatening airway injury characterized by airway obstruction from fibrin casts, which can lead to respiratory failure and death. Mortality in those requiring intubation is more than 80%. No therapy exists to prevent mortality after SM exposure. Our previous work using the less toxic analog of SM, 2-chloroethyl ethyl sulfide, identified tissue plasminogen activator (tPA) an effective rescue therapy for airway cast obstruction (Veress, L. A., Hendry-Hofer, T. B., Loader, J. E., Rioux, J. S., Garlick, R. B., and White, C. W. (2013). Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am. J. Respir. Cell Mol. Biol. 48, 439-447). It is not known if exposure to neat SM vapor, the primary agent used in chemical warfare, will also cause death due to airway casts, and if tPA could be used to improve outcome. METHODS: Adult rats were exposed to SM, and when oxygen saturation reached less than 85% (median: 6.5 h), intratracheal tPA or placebo was given under isoflurane anesthesia every 4 h for 48 h. Oxygen saturation, clinical distress, and arterial blood gases were assessed. Microdissection was done to assess airway obstruction by casts. RESULTS: Intratracheal tPA treatment eliminated mortality (0% at 48 h) and greatly improved morbidity after lethal SM inhalation (100% death in controls). tPA normalized SM-associated hypoxemia, hypercarbia, and lactic acidosis, and improved respiratory distress. Moreover, tPA treatment resulted in greatly diminished airway casts, preventing respiratory failure from airway obstruction. CONCLUSIONS:tPA given via airway more than 6 h after exposure prevented death from lethal SM inhalation, and normalized oxygenation and ventilation defects, thereby rescuing from respiratory distress and failure. Intra-airway tPA should be considered as a life-saving rescue therapy after a significant SM inhalation exposure incident.
Authors: David H Fitchett; Pierre Theroux; James M Brophy; Warren J Cantor; Jafna L Cox; Milan Gupta; Heather Kertland; Shamir R Mehta; Robert C Welsh; Shaun G Goodman Journal: Can J Cardiol Date: 2011 Nov-Dec Impact factor: 5.223
Authors: Raymond C Rancourt; Livia A Veress; Xiaoling Guo; Tara N Jones; Tara B Hendry-Hofer; Carl W White Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-09-30 Impact factor: 5.464
Authors: Matthew D McGraw; Marilyn M Dysart; Tara B Hendry-Hofer; Paul R Houin; Jaqueline S Rioux; Rhonda B Garlick; Joan E Loader; Russell Smith; Danielle C Paradiso; Wesley W Holmes; Dana R Anderson; Carl W White; Livia A Veress Journal: Am J Respir Cell Mol Biol Date: 2018-06 Impact factor: 6.914
Authors: Obiefuna C Okponyia; Matthew D McGraw; Marilyn M Dysart; Rhonda B Garlick; Jacqueline S Rioux; Angela L Murphy; Gates B Roe; Carl W White; Livia A Veress Journal: Am J Respir Cell Mol Biol Date: 2018-01 Impact factor: 6.914
Authors: Eleanor M Summerhill; Gary W Hoyle; Sven-Eric Jordt; Bronwen J Jugg; James G Martin; Sadis Matalon; Steven E Patterson; David J Prezant; Alfred M Sciuto; Erik R Svendsen; Carl W White; Livia A Veress Journal: Ann Am Thorac Soc Date: 2017-06
Authors: Galina Florova; Ali O Azghani; Sophia Karandashova; Chris Schaefer; Serge V Yarovoi; Paul J Declerck; Douglas B Cines; Steven Idell; Andrey A Komissarov Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-08-31 Impact factor: 5.464
Authors: Cameron S McElroy; Elysia Min; Jie Huang; Joan E Loader; Tara B Hendry-Hofer; Rhonda B Garlick; Jackie S Rioux; Livia A Veress; Russell Smith; Chris Osborne; Dana R Anderson; Wesley W Holmes; Danielle C Paradiso; Carl W White; Brian J Day Journal: Toxicol Sci Date: 2016-09-07 Impact factor: 4.849
Authors: Matthew D McGraw; Christopher M Osborne; Emily J Mastej; Jorge A Di Paola; Dana R Anderson; Wesley W Holmes; Danielle C Paradiso; Rhonda B Garlick; Tara B Hendry-Hofer; Raymond C Rancourt; Russell W Smith; Carol Burns; Gates B Roe; Jacqueline S Rioux; Carl W White; Livia A Veress Journal: Toxicol Sci Date: 2017-10-01 Impact factor: 4.849